February 2019

Value-Based Arrangements May Be More Prevalent Than Assumed

February 13, 2019


We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.

Impact of Hepatitis C Virus and Insurance Coverage on Mortality

February 07, 2019


The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.

Performance of the Adapted Diabetes Complications Severity Index Translated to ICD-10

February 01, 2019


We present an International Classification of Diseases, Tenth Revision (ICD-10) translation of the adapted Diabetes Complications Severity Index and show its performance in predicting hospitalizations, mortality, and healthcare-associated costs.

Are Value-Based Incentives Driving Behavior Change to Improve Value?

January 31, 2019


Value-based payment is promoting care delivery transformation among California physician organizations, although the initial focus has been on controlling hospital costs and redesigning primary care.

The Drug Price Iceberg: More Than Meets the Eye

January 30, 2019


When it comes to the political iceberg of drug prices, there is more than meets the eye. Policies that reduce prices but do not lower consumers’ out-of-pocket costs will not address the main challenge facing most Americans.